Insiders · Profile

Schoell Josef

Chief Financial Officer at Tvardi Therapeutics. Filing since 17 Feb 2015. CIK 0001597186

Company
Date
Role
Action
Shares
Amount
Of holding
18 Aug 2015
Chief Financial Officer
Bought
3,000
$66.30K
12.0%
17 Feb 2015
Chief Financial Officer
Sold, plan not stated
15,000
$164.40K
37.5%
2 decisions on file.